- Price
- $41.91
- Day
- +0.02%
- Mkt Cap
- $4.67B
- 52W Range
- $33.03 – $60.63
- Volume
- 2.90M
- Beta
- 1.28
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
ALK adds daily 737-800 service on select Honolulu-Kahului flights, boosting inter-island capacity and premium amenities in Hawaii.
Read full article
-- Topline Phase 1 data shows generally favorable safety and tolerability profile of AGMB-447 -- -- Pharmacokinetic profile confirms efficient lung restriction with low systemic exposure and high exposure of AGMB-447 in the lung, in line with prior results observed in healthy participants -- -- Robust target engagement of ALK5 observed with AGMB-447 in IPF patients -- -- Clinical Trial Application (CTA) for INSPIRIA Phase 2 study in IPF patients submitted; Company intends to initiate study before year-end -- Antwerp, Belgium, September 14, 2026 – Agomab Therapeutics NV (‘Agomab'), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced positive results of the Phase 1 study of AGMB-447 in IPF patients. AGMB-447 is an investigational inhaled lung-restricted small molecule inhibitor of ALK5 (or TGFβR1) intended for the treatment of Idiopathic Pulmonary Fibrosis (IPF).1 The Phase 1 study of AGMB-447 is a three-part, double-blind, randomized, placebo-controlled single ascending dose (SAD; Part A; dose range: 1 mg QD (once daily) to 20 mg QD) and multiple ascending dose (MAD; Part B; dose range: 1 mg QD to 6 mg BID (twice daily)) study in healthy participants and multiple dose study in IPF patients (Part C; dose range: 4.5 mg BID to 6 mg BID).
Read full article
Alaska Air Group (ALK) concluded the recent trading session at $40.71, signifying a -1.09% move from its prior day's close.
Read full article
Hsbc Holdings PLC lowered its stake in Alaska Air Group, Inc. (NYSE: ALK) by 65.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 65,242 shares of the transportation company's stock after selling 122,254 shares during the quarter. Hsbc Holdings PLC
Read full article
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company's Executive Vice President and CFO, Claus Steensen Sølje, is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City taking place from 14 - 16 September 2026 on Monday, 14 September 2026, at 3.20 PM EDT.
Read full article
PERTH, Australia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane' or ‘the Company') is pleased to summarise the latest update to the Mineral Resource and Ore Reserve estimates for its assets in Australia and Sweden as at 30 June 2026.
Read full article
ALK expands in San Diego with seasonal nonstop service to Loreto, its 50th destination, while investing in loyalty and passenger experience.
Read full article
In the closing of the recent trading day, Alaska Air Group (ALK) stood at $40.74, denoting a -3.09% move from the preceding trading day.
Read full article
LOS ANGELES--(BUSINESS WIRE)--On September 1, UNITE HERE Local 11 and UNITE HERE Local 2 filed a formal complaint asking Alaska Air Group to enforce its Supplier Code of Conduct against inflight caterer Flying Food Group (FFG), which provides catering services to Alaska subsidiary Hawaiian Airlines at Los Angeles International Airport and provided catering services to San Francisco International Airport until earlier this year. The complaint asks Alaska to cease sourcing from FFG until the comp.
Read full article